Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2025-12-24 @ 12:03 PM
NCT ID:
NCT02416661
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients aged 6 months or older
* Patients with genetically confirmed diagnosis of Gaucher disease type 1
* No prior treatment with enzyme replacement therapy or substrate reduction therapy ro no traetment for more than 24 months
* Signed informed consent by parents/legal guardian and patient
Exclusion Criteria:
* Male or female patients being younger than 6 months
* Patients without genetically confirmed diagnosis of Gaucher disease type 1
* Gaucher disease 2 or 3
* Patient is currently undergoing enzyme replacement therapy or substrate reduction therapy
* Missing signed informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Study:
NCT02416661
Study Brief:
Protocol Section:
NCT02416661